candesartan and (3S,5S,6E)-7-[3-(4-fluorophenyl)-1-(propan-2-yl)-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid

candesartan has been researched along with (3S,5S,6E)-7-[3-(4-fluorophenyl)-1-(propan-2-yl)-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bleeke, T; Chen, X; Friedrich, S; Niroomand, F; Tiefenbacher, CP; Vahl, C	1

Other Studies

1 other study(ies) available for candesartan and (3S,5S,6E)-7-[3-(4-fluorophenyl)-1-(propan-2-yl)-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid

Article	Year
ACE inhibitors and statins acutely improve endothelial dysfunction of human coronary arterioles. American journal of physiology. Heart and circulatory physiology, 2004, Volume: 286, Issue:4 Topics: Acetylcholine; Aged; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Arterioles; Arteriosclerosis; Benzimidazoles; Biphenyl Compounds; Coronary Disease; Coronary Vessels; Endothelium, Vascular; Fatty Acids, Monounsaturated; Female; Fluvastatin; Histamine; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Indoles; Lisinopril; Male; Middle Aged; Muscle Contraction; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Nitric Oxide Synthase Type I; Nitroprusside; Serotonin; Tetrazoles; Vascular Diseases; Vascular Resistance; Vasodilator Agents	2004

Article

Year

ACE inhibitors and statins acutely improve endothelial dysfunction of human coronary arterioles.

American journal of physiology. Heart and circulatory physiology, 2004, Volume: 286, Issue:4

Topics: Acetylcholine; Aged; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Arterioles; Arteriosclerosis; Benzimidazoles; Biphenyl Compounds; Coronary Disease; Coronary Vessels; Endothelium, Vascular; Fatty Acids, Monounsaturated; Female; Fluvastatin; Histamine; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Indoles; Lisinopril; Male; Middle Aged; Muscle Contraction; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Nitric Oxide Synthase Type I; Nitroprusside; Serotonin; Tetrazoles; Vascular Diseases; Vascular Resistance; Vasodilator Agents

2004